Science - Or not? The status and dynamics of biotechnology

Biotechnology Journal

Volumn 2, Issue 9, 2007, Pages 1154-1168

  Buchholz, Klaus ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Biotechnology; Development; History; Scientific status of biotechnology

Indexed keywords

BIOCHEMISTRY; BIOTECHNOLOGY; DYNAMICS; EDUCATION; GENETIC ENGINEERING; GERMANY; GOVERNMENT; INDUSTRY; INTERVIEW; METHODOLOGY; MOLECULAR BIOLOGY; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESEARCH; REVIEW; THEORY; UNITED STATES;

BIOTECHNOLOGY; INDUSTRY; INTERNATIONALITY; RESEARCH; SCIENCE;

EID: 34948843973     PISSN: 18606768     EISSN: None     Source Type: Journal    
DOI: 10.1002/biot.200600222     Document Type: Review

References (76)

1. Dechema, Biotechnologie. Dechema, Frankfurt 1974.
2. OTA (US Office of Technology Assessment), Impact of Applied Genetics, Washington, 1984, pp. 67-70.
3. Lakatos, I., Falsification and the methodology of scientific research programmes, in: Musgrave, J. L. (Ed.), Criticism and the Growth of Knowledge, Cambridge University Press, London 1970, pp. 91-196.
4. Kuhn, T. S., Die Struktur wissenschattlicher Revolutionen, Suhrkamp Verlag, Frankfurt, 1973.
5. Buchholz, K., Verfahrenstechnik. Its development, present state and structure. Social Studies Sci. 1979, 9, 33-62.
6. Buchholz, K., Criteria for the analysis of scientific quality. Scientometrics 1995, 32, 195-218.
7. Van den Daele, W., Krohn, W., Weingart, P, Die politische Steuerung der wissenschaftlichen Entwicklung, in: van den Daele, W., Krohn, W., Weingart, P, (eds.), Geplante Forschung, Suhrkamp Verlag, Frankfurt 1979, pp. 11-63.
8. Hoffmann, R., Personal communication, 2005.
9. Buchholz, K., Die gezielte F6rderung und Entwicklung der Biotechnologie, in: van den Daele W, Krohn W, Weingart P. (eds.) Geplante Forschung, Suhrkamp Verlag, Frankfurt 1979, pp. 64-116.
10. Bud, R., In the engine of industry: Regulators of biotechnology, 1970-1986 in: Bauer, M. (ed.), Resistance to New Technology, Cambridge University Press, Cambridge 1994, pp. 293-309.
11. Bud, R., The Uses of Life, A LUstory of Biotechnology, Cambridge University Press, Cambridge 1993, Bud, R., Wie wir das Leben nutzhar machten, Vieweg, Braunschweig/Wiesbaden, 1996, pp. 183-212.
12. Jasanoff, S., Technological innovation in a corporatist state: The case of biotechnology in the Federal Republic of Germany, Res Policy 1985, 14, 23-38.
13. Cohen, S., Chang, A. C. Y., Hsu L., Nonchromosomal antibiotic resistance in bacteria: Genetic transformation of E. coli by R-factor DNA, Proc. Nat]. Acad. Sci. USA 1972, 69, 2110-2114.
14. Cohen, S., Boyer, H., Process for producing biologically functional molecular chimeras. US Patent 4, 237, 224, 1979/1980.
15. Marschall, L., Technikgeschichte 1999, 66, 277-293.
16. Buchholz, K., Historical highlights and current status of biotechnology-From mystery to the lock and key hypothesis to the design of recombinant enzymes, Med. Chain. Res. 2003, 11, 399-421.
17. Hotchkiss, R. D., The Identification of Nucleic Acids as Genetic Determinants, in: The Origins of Modern Biochemistry, Srinivasan, P R., Fruton, J. S., Edsall, J. T. (eds.) New York Academy of Sciences, New York 1979, pp. 321-342
18. Watson, J. D., Crick, F. H. C., The structure of DNA, in: Cold Spring Harbor Symposia on Quantitative Biology, Vol. XVIII, Viruses, The Biological Laboratory, Cold Spring Harbor, L. I., New York 1953, pp. 123-131.
19. Stryer, L., Biochemistry, W. H. Freeman, New York 1995, p. 118-120.
20. Demain, A. L., Personal communications 2003.
21. Ono, D., The Business of Biotechnology, Butterworth-Heinemann, Stoneham, MA, USA 1991, Table 7-2.
22. Kombeig, A., The Golden Helix, Inside Biotech Ventures, University Science Books, Sausalito, Califorrua, USA 1995.
23. Berg, P., Potential Bichazaids of recombinant DNA molecules, Proc. Natl. Acad. Sci. USA 1974, 71, 2593-2594.
24. Glick, B. R., Pasternak~ J. J., Molecular Biotechnology, Principles & Applications of Recombinant DNA, ASM Press, Washington 1994.
25. Demain, A. L., Genetics and microbiology of industrial microorganisms. Molecular genetics and industrial microbiology - 30 years of marriage, J. Ind. Microb. Biotechnol. 2001, 27, 352-356
26. Buchholz, K., Poulson, P B., Introduction/Overview of History of Applied Biocatalysis, in: Straathof. A. J. J., Adlercreutz, P. (eds.), Applied Biocatalysis. Harwood, Amsterdam 2000.
27. Stemmer, W. P C., Rapid evolution of a protein in vitro by DNA shuffling, Nature 1994, 370, 389-391.
28. Arnold, F, Moore, J. C., Optimizing industrial enzymes by directed evolution. Adv. Biochem. Eng. 1997, 58, 1-14.
29. Beier, L., Svendsen, A., Andersen, C., Frandsen, T. P, Borchert, T. V, Cherry, J. R., Conversion of the maltogenic α-amylase Novamyl into a CGTase. Protein Eng. 2000, 13, 509-513.
30. Buchholz, K., Kasche, V, Bornscheuei, U., Biocatalysts and Enzyme Technology, Wiley-VCH, Weinheim 2005.
31. Sinskey, A. J., Foreword. Metab. Eng. 1999, 1, iii-v.
32. Stephanopoulos, G., Metabolic fluxes and metabolic engineering. Metab. Eng. 1999, 1, 1-11.
33. Reuss, M., Editorial. Bioprocess Biosyst. Eng. 2001, 24, 1.
34. Gerstein, M., Integrative database analysis in structural genomics. Nature Struct. Biol. Structural Genornics Supplement, 2000, (Nov), 960-963.
35. Engineering Foundation (New York), Conference on Metabolic Engineering, Elmau, Germany 1998. Reuss, M., Sinskey, A. J. (eds.), Foreword. Metab. Eng. 1999, 1, iii-v.
36. Stephanopoulos, G., Vallino, J. J., Network rigidity and metabolic engineering in metabolite overproduction, Science 1991, 252, 1675-1681.
37. Rizzi, M., Baltes, M., Theobald, U., Reuss, M., In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: II. Mathematical model, Biotechnol. Bioeng. 1997, 55, 592-608.
38. Christensen, B., Nielsen, J., Metabolic network analysis of Penicillium chrysogenum using 13C-labeled glucose, Biotechnol. Bioeng. 2000., 68, 652-659.
39. Lorenz, P, Eck, J., Metagenomics and industrial applications. Nat. Rev Microbiol. 2005, 3, 510-516.
40. Vidal, M., A Biological Atlas of Functional Maps. Cell 2001, 104, 333-339.
41. Goehler, H., Lalowski, M., Stelzl, U., Waelter, S. et al., A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell. 2004, 15, 853-865.
42. Wassaf, D, et al., High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays, Anal. Biochem. 2006, 351, 241-53,
43. Seibel, J., Hellmuth, H., Hofer, B., Schmalbruch, B., Identification of new donor specificities of glycosyltransferases R via the aid of substrate microarrays, Chem Bio Chem 2006, 7, 310-320.
44. Marx, A., Eilcmanns, B. J., Sahm, H., de Graaf, A. A., Eggeling, L., Response of the central metabolism in Corynebacterium glutamicum to the use of an NADH-dependent glutamate dehydrogenase. Metabol. Eng. 1999, 1, 35-48.
45. Gulic, van W. W de Laat, W. T. A. M., Vinke, J. L., Heijnen, J. J., Application of metabolic flux analysis for the identification of metabolic bottlenecks in the biosynthesis of penicillin-G. Biotechnol. Bioeng. 2000, 68, 602-618.
46. Anderson, S., Berman Marks, C., Lazarus, R., Miller, J., Stafford, K., Seymour, J., Light, D., Rastetter, W., Estell, D., Production of 2-Keto-L-Gulonate, an Intermediate in L-Ascorbate Synthesis by a Genetically Modified Erwinia herbicola. Science 1985, 230, 144-149.
47. Grindley, J. F, Payton, M. A., van den Pol, H., Hardy, G., Conversion of Glucose to 2-Keto-L-Gulonate, an Intermediate in L-Ascorbate Synthesis, by a Recombinant Strain of Erwinia citreus. Appl. Env. Microb. 1988, 54, 1770-1775.
48. Jördening, H.-J., Winter, J., Environmental Biotechnology, Wiley-VCH, Weinheirn 2004.
49. U. S. Department of Energy, Energy Efficiency and Renewable Energy, Biomass: Top Value Added Chemicals from Biomass, Werpy, T., Petersen, G., (eds.), U. S. Department of Commerce, Springfield, VA, USA 2004, p. 11-13.
50. Decherna, Weisse Biotechnologie, Positionspapier, Dechema, Frankfurt 2004, pp. 6-38.
51. O'Driscoll, C., An insatiable hunger, Chem. & Ind. 2006, 2. Oct, 24-27.
52. Lähteenmäki, R., Lawrence, S., Public biotechnology 2004 - the numbers. Nat. Biotechnol. 2005, 23, 663-671.
53. Lähteenmäki, R., Lawrence, S., Public biotechnology 2005 - the numbers. Nat. Biotechnol. 2006, 24, 625-634.
54. Winnacker, E. L., From Genes to Clones, VCH, Weinheim, Germany 1987, pp. 483-485.
55. OTA (US Office of Technology Assessment), Impact of Applied Genetics, Washington, 1984, pp. 355, 489, 550, 577.
56. DeFrancesco, L., Profile: Fritjof Capra, Nat. Biotechnol. 2004, 22, 1201-1202.
57. Snyder, E. Y., Hinman, L. M., Kalichman, M. W., Can science resolve the ethical impasse in stem cell research? Nat. Biotechnol. 2006, 24, 397-400.
58. Caulfield, T., Einsiedel, E., Merz, J. F, Nicol, D., Trust, patents and public perceptions: the governance of controversial biotechnology research, Nat. Biotechnol. 2006, 24, 1352-1354.
59. van den Daele, W., Pidliler, A., Sukopp, H., Grüne Gentechnik im Widerstreit, VCH, Weinheim (Germany) 1996.
60. Lassen, J., Madsen, K. H., Sandoe, P, Ethics and Genetic Engineering-lessons to be learned from GM foods. Bioprocess Biosyst. Eng. 2002, 24, 263-271.
61. WCED-World Conimission on Environment and Development. Our common future, Oxford Univ. Press, Oxford 1987.
62. Hoffmann, R., Why buy that theory? Am. Sci. 2003, 91, 9-11.
63. Florkin, M., A History of Biochemistry, in: Comprehensive Biochemistry, Florkin, M., Stotz, E. H. (Eds.), Vol. 30, Elsevier 1972
64. EFB, Biotechnology in Europe - A Community Strategy for European Biotechnology. European Federation of Biotechnology. Dechema, Frankfurt 1983.
65. Mann, M., Hendrickson, R. C., Pandey, A., Analysis of Proteins and Proteomes by Mass Spectrometry. Ann, Rev Biochem. 2001, 70, 437-473.
66. Podtelejnikov, A., Mann, M., Identification of Yeast Proteins by Mass Spectrometry, Methods Enzymol. 2002, 351, 296-321.
67. Anon. transkript-Laborwelt, Analytica, 2000, pp. 25-27,10-16,19-20, 21-24(52); Ernst & Young. 2001. Cited in Jahresbericht, VCI, Frankfurt, 2001, 24.
68. Theobald, U., Mailinger, W, Baltes, M., Rizzi, M., Reuss, M., In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: I. Experimental observations. Biotechnol. Bioeng. 1997 55, 305-316.
69. Conejeros, R., Vassiliadis, V S., Dynamic biochemical reaction process analysis and pathway modification predictions. Biotechnol. Bioeng. 2000, 68, 285-297.
70. Hempel, D., Development of Biotechnical Processes by Integrating Genetic and Engineering Methods. Eng. Life Sci. 2006, 6, 443-447.
71. Macer, D., Nature-and-Resources. 1997, 33(2), 2-13.
72. van den Daele, W, Mensch nach Maß?, C. H. Beck, München 1985.
73. Scott, C. T., Stem Cell Now: From the Experiment That Shook the World to the New Politics of Life, Pi Press, 2005, ISBN 0-13-173798-8 (reviewed in [74]).
74. Jennings, C. G., Sense about stem cells. Nature Biotechnol. 2006, 24, 623-625.
75. Beckwith, J., Huang, F, Should we make a fuss? A case for social responsibility in science. Nat. Biotechnol. 2005, 23, 1479-1480.
76. Moreno, J. D., Hynes, R, O., Guidelines for human embryonic stem cell research. Nat. Biotechnol. 2005, 23, 793-794.